DRAFT VARIATION TO THE HMDA FOR CHANGE OF LAND USE FROM RESIDENTIAL USE ZONE TO MANUFACTURING USE ZONE FOR SETTING UP UNIT OF PHARMACEUTICAL FORMULATION AN FOR R & D PURPOSE (FOR SUSTAINED RELEASE/EXTENDED RELEASE OF DRUGS ONLY AND NOT FOR COMMERCIAL PURPOSE) UNDER ‘ORGANGE’ CATEGORY RECEIVED UNDER TG-IPASS WITH APPLIED BY M/s. HETERO LABS LIMITED REPRESENTED BY A SUDHAKAR REDDY. DRAFT VARIATION TO THE HMDA FOR CHANGE OF LAND USE FROM RESIDENTIAL USE ZONE TO MANUFACTURING USE ZONE FOR SETTING UP UNIT OF PHARMACEUTICAL FORMULATION AN FOR R & D PURPOSE (FOR SUSTAINED RELEASE/EXTENDED RELEASE OF DRUGS ONLY AND NOT FOR COMMERCIAL PURPOSE) UNDER ‘ORGANGE’ CATEGORY RECEIVED UNDER TG-IPASS WITH APPLIED BY M/s. HETERO LABS LIMITED REPRESENTED BY A SUDHAKAR REDDY.

click here for IIIF manifest

[ Price : . 5-00.

R.N.I. No. TELMUL/2016/73158.

HSE No. 1051/2026-2028.

THE TELANGANA GAZETTE

PART-II EXTRAORDINARY

PUBLISHED BY AUTHORITY

No. 215-A] HYDERABAD, THURSDAY, MARCH 12, 2026.

NOTIFICATIONS BY HEADS OF DEPARTMENTS, Etc.

–––x–––

HYDERABAD METROPOLITAN DEVELOPMENT AUTHORITY

DRAFT VARIATION TO THE HMDA FOR CHANGE OF LAND USE FROM RESIDENTIAL USE ZONE TO MANUFACTURING USE ZONE FOR SETTING UP UNIT OF PHARMACEUTICAL FORMULATION AN FOR R & D PURPOSE (FOR SUSTAINED RELEASE/EXTENDED RELEASE OF DRUGS ONLY AND NOT FOR COMMERCIAL PURPOSE) UNDER 'ORGANGE' CATEGORY RECEIVED UNDER TG-IPASS WITH APPLIED BY M/s. HETERO LABS LIMITED REPRESENTED BY A SUDHAKAR REDDY.

[ 1 ]

G-1.

DRAFT VARIATION TO THE HMDA FOR CHANGE OF LAND USE FROM CONSERVATION USE TO MANUFACTURING USE FOR SETTING UP UNIT WITH LINE OF MANUFACTURE OF CBG CNG UNDER 'WHITE' CATEGORY RECEIVED UNDER TS-IPASS WITH APPLIED BY M/ s. BLUELEO ENERGY REPRESENTED BY SRI. DEVULAPALLY ADITYA NARASIMHA REVANT.

Hyderabad, 12-03-2026.

Sd/-

Chief Planning Officer (PR).

–––x–––

Printed and Published by the Commissioner of Printing, Government of Telangana at Government Central Press, Chanchalguda, Hyderabad.